Eli Lilly and Company CEO Dave Ricks told CNBC in an interview on Wednesday that his firm doesn't support United States President Donald Trump's efforts to turn "most favored nation" drug pricing initiatives into law.
A number of pharmaceutical companies, including Eli Lilly, previously signed agreements on lowering drug prices, thinking that this would appease the administration. Speaking about the government's wish to make this into a law, Ricks said that "when you throw it into the congressional process, what goes in is not what's going to come out."
He went on to add that Eli Lilly will use "all the tools [it has] to combat bad policy, and we think it would be bad policy."
https://breakingthenews.net/Article/Eli-Lilly-against-'most-favored-nation'-pricing-law/66000151
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.